Cystourethroscopes

Welcome to Cystourethroscopes Site
Cystourethroscopes Resources

Home > Cystourethroscopes > Medtech Startups, April 2008

Medtech Startups, April 2008




New medical technologies represented in companies added (April 2008) to the Medtech Startups Database and/or added to the April 2008 issue of MedMarkets:

  • Acquired vascular business of surgical/orthopedic manufacturer
  • Stromal Cell-Derived Growth Factor-1 (SDF-1) to attract stem cells and stimulated tissue regeneration in damaged heart tissue.
  • Stents (tantalum, zirconium, niobium, and/or tungsten)
  • Nanotechnology-based gene therapy for congestive heart failure.
  • Ultrasound catheter
  • Undisclosed technology
  • Soft tissue repair products and products used in soft tissue repair procedures
  • Design and development of medical devices for vascular access site hemostasis
  • Minimally invasive tumor removal from brain and central nervous system tissue
  • Knee alignment system to preserve knee surfaces and restore normal activity.
  • Device to detect changes in the endothelium to potentially predict coronary artery disease and stroke.
  • Orthopedic and spinal anchoring implants for use in spine surgery.
  • Device for treatment of chronic head and neck pain.
  • Medical device company launched by venture capital firm/incubator.
  • Device and methods to treat low back pain.
  • Medical device technology platform company focused on cardiovascular applications, including a percutaneous venous valve, inferior vena cava filter, laparoscopic scissor grasper, and Parodi guidewire.
  • Mesh device technologies to facilitate laparoscopic surgery.
  • Mineral-based hemostatic compound for use in stopping arterial bleeding.
  • Novel advanced damaged tissue care systems.
  • Devices to facilitate knee replacement




Spine Surgery 2008 Now Published!: Spine Surgery: Products, Technologies, Markets & Opportunities, Worldwide, 2008-2017 see link

For coverage in specific issues of MedMarkets, see link.

For details on the Medtech Startups Database, see link.

Subscribe to MedMarkets and receive 20% discount off any MedMarket Diligence report.  Contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com for details.


Tags: medtech, startup


Click Here to read the entire article...




Other Articles:


Five States Step Up Efforts To Screen Newborns For Cystic Fibrosis
Four states-- Arkansas, Kansas, Maine, and West Virginia--have joined 40 others and the District of Columbia in requiring that all newborns be screened for cystic fibrosis (CF) at birth. In addition, Utah has cleared the way to begin regular CF screening as well. Routine screening is expected to begin January 1, 2009.
Click Here to read the entire article...
Listen to The Lancet: 21 June
Drug-eluting stents revolutionised interventional cardiology owing to their pronounced ability to reduce restenosis compared with bare-metal stents. Attention has now shifted to safety of these devices because of evidence suggesting an association with late stent thrombosis. In a review, Anthony Bavry and Deepak Bhatt assess current evidence from randomised trials, and propose guidelines for the appropriate use of drug-eluting stents in clinical practice. Deepak Bhatt discusses the history of stents and assesses our current knowledge and considers treatment options for cardiologists and patients in this week's podcast.
Click Here to read the entire article...
ASCB Statement on Senate Passage of H.R. 810, the Stem Cell Research Enhancement Act
For the second time in as many years, our nation's lawmakers are about to debate the expansion of the federal government's policy regarding the funding of human embryonic stem cell research.
Click Here to read the entire article...
Zoom RhythmTrak RT-223 - USED
£38.00 (0 Bid)
End Date: Monday Aug-04-2008 22:43:54 BST
Bid now | Add to watch list
Click Here to read the entire article...
Obesity not a contraindication to knee replacement (Reuters)
Reuters - Obese individuals with arthritic knees should not be denied knee replacement surgery, researchers conclude, based on a new study showing that obese patients benefit from the surgery almost as much as their normal-weight peers.
Click Here to read the entire article...
[Microbiology] HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision

We previously proposed that mutations in the connection subdomain (cn) of HIV-1 reverse transcriptase increase AZT resistance by altering the...

Click Here to read the entire article...
New Medical Technology Companies, from MedMarket Diligence, LLC
By info@mediligence.com - Copyright 2006, MedMarket Diligence, LLC - version: v1.5 build A